Home
About
Overview
Sharing Data
ORCID
Help
History (1)
An Ethical and Financial Obligation for Sickle Cell Disease Gene Therapy in the United States.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
An Ethical and Financial Obligation for Sickle Cell Disease Gene Therapy in the United States.
An Ethical and Financial Obligation for Sickle Cell Disease Gene Therapy in the United States. Ann Intern Med. 2024 01; 177(1):85-86.
View in:
PubMed
subject areas
Anemia, Sickle Cell
Genetic Therapy
Humans
United States
authors with profiles
Monica Peek
Mark J. Ratain